`

Arbutus Biopharma Corporation

Biotechnology Research

revenue-icon Revenue
1M - 10M
funding-icon Total Funding
--
size-icon Size
51 - 200

Frequently Asked Questions About Arbutus Biopharma Corporation

What does Arbutus biopharma corporation do?+

Arbutus Biopharma Corporation (Nasdaq: ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). We believe the key to success in developing a functional cure involves suppressing HBV DNA, reducing surface antigen, and boosting HBV-specific immune responses. Our pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. Imdusiran has generated meaningful clinical data demonstrating an impact on both surface antigen reduction and...

What is Arbutus biopharma corporation's industry? +

Arbutus biopharma corporation operates in the Biotechnology research industry.

What is Arbutus biopharma corporation's revenue? +

Arbutus biopharma corporation's revenue is 1m - 10m

What is Arbutus biopharma corporation's company size? +

Arbutus biopharma corporation has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.